| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | -86.8% |
| Cost of Revenue | $100K | -50.0% |
| R&D Expense | $20.3M | +29.3% |
| SG&A Expense | $12.6M | +11.1% |
| Operating Income | -$42.0M | -65.8% |
| Pre-tax Income | -$41.3M | -97.3% |
| Income Tax | $0 | +100.0% |
| Net Income | -$41.3M | -99.5% |
| EPS (Basic) | -$2.13 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.1M | -19.8% |
| Current Assets | $17.8M | -22.9% |
| Total Assets | $20.9M | -20.3% |
| Current Liabilities | $15.5M | +211.4% |
| Total Liabilities | $16.1M | +171.5% |
| Stockholders' Equity | $4.9M | -76.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.8M | +8.5% |
| Investing Cash Flow | -$4.5M | — |
| Financing Cash Flow | $24.1M | +99.4% |
| -59.0% |
| EPS (Diluted) | -$2.13 | -59.0% |